Bipolar disorder and schizophrenia: Distinct illnesses or a continuum?

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 6, 2003, Pages 23-27

  Möller, Hans Jürgen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIPOLAR DISORDER; DEPRESSION; DISEASE SEVERITY; GENE MAPPING; GENETIC PREDISPOSITION; HUMAN; MANIA; PRIORITY JOURNAL; SCHIZOPHRENIA;

BIPOLAR DISORDER; DIAGNOSIS, DIFFERENTIAL; HUMANS; LINKAGE (GENETICS); SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0038731292     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Evans DL. Bipolar disorder: diagnostic challenges and treatment considerations. J Clin Psychiatry 2000;61(suppl 13):26-31
2. Bowden CL. Update on bipolar disorder: epidemiology, etiology, diagnosis, and prognosis. Available at: http: //linkage.rockefeller.edu/wli/reading/ bipolar.html. Accessed Feb 5, 2002
3. Emental-health.com. History of bipolar disorder. Available at: http://www.emental-health.com/bipo_history.htm. Accessed Feb 5, 2002
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
5. World Health Organization. The International Statistical Classification of Diseases and Related Health Problems, 10th rev. Available at: http://www.who.int/whosis/icd10. Accessed Feb 4, 2003
6. Muller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet 2002;359:241-247
7. Varma SL. Genefics of schizophrenia and affective disorder: an overlap. Psychiatry On-Line, 1997. Available at: http://www.priory.com/psych/ genetics.htm. Accessed Feb 5, 2002
8. Bertelsen A, Harvald B, Hauge M. A Danish twin study of manicdepressive disorders. Br J Psychiatry 1977;130:330-351
9. Cardno AG, Marshall EJ, Coid B, et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 1999;56:162-168
10. Gershon ES, Hamovit J, Guroff JJ, et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 1982;39:1157-1167
11. Gershon ES, DeLisi LE, Hamovit J, et al. A controlled family study of chronic psychoses: schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 1988;45:328-336
12. Angst J, Frey R, Lohmeyer B, et al. Bipolar manic-depressive psychoses: results of a genetic investigation. Hum Genet 1980;55:237-254
13. Dalby JT, Morgan D, Lee ML. Schizophrenia and mania in identical twin brothers. J Nerv Ment Dis 1986;174:304-308
14. Berrettini WH. Are schizophrenic and bipolar disorders related? a review of family and molecular studies. Biol Psychiatry 2000;48:531-538
15. Torrey EF. Epidemiological comparison of schizophrenia and bipolar disorder. Schizophr Res 1999;39:101-106
16. Aubert JL, Rush AJ. Schizoaffecfive disorder. In: Widiger TA, Frances AJ, Pincus HA, et al, eds. DSM-IV Sourcebook, vol 2. Washington, DC: American Psychiatric Association; 1996:65-96
17. Altshuler LL, Bartzokis G, Grieder T, et al. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. Arch Gen Psychiatry 1998;55:663-664
18. Strakowski SM, DelBello MP, Sax KW, et al. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry 1999;56:254-260
19. Hulshoff Pol HE, Schnack HG, Mandl RC, et al. Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry 2001;58:1118-1125
20. Strakowski SM, DelBello MP, Adler C, et al. Neuroimaging in bipolar disorder. Bipolar Disord 2000;2(3 pt 1):148-164
21. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord 2001;3:106-150
22. Nasrallah HA, McCalley-Whitters M, Jacoby CG. Cortical atrophy in schizophrenia and mania: a comparative CT study. J Clin Psychiatry 1982;43:439-441
23. Stoll AL, Renshaw PF, Yurgelun-Todd DA, et al. Neuroimaging in bipolar disorder: what have we learned? Biol Psychiatry 2000;48:505-517
24. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48:813-829
25. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 2001;49:741-752
26. Berrettini WH. Molecular linkage studies of bipolar disorders. Bipolar Disord 2001;3:276-283
27. Manji HK, Lenox RH. The nature of bipolar disorder. J Clin Psychiatry 2000;61(suppl 13):42-57
28. Laruelle M, Abi-Dargham A, Gil R, et al. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 1999;46:56-72
29. Abi-Dargham A, Gil R, Krystal J, et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 1998;155:761-767
30. Ko GN, Leckman JF, Heninger GR. Induction of rapid mood cycling during L-dopa treatment in a bipolar patient. Am J Psychiatry 1981;138:1624-1625
31. Harsch HH, Miller M, Young LD. Induction of mania by L-dopa in a nonbipolar patient. J Clin Psychopharmacol 1985;5:338-339
32. Murphy DL, Brodie HK, Goodwin FK, et al. Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients. Nature 1971;229:135-136
33. IA Receptor dysfunction in female patients with schizophrenia. Biol Psychiatry 2001;50:758-766
34. Duval F, Mokrani MC, Bailey PE, et al. Dopaminergic and serotonergic function in untreated schizophrenia. Presented at the 56th Scientific Convention of the American Society of Biological Psychiatry; May 3-5, 2001; New Orleans, La
35. IA receptor activity. Neuropsychobiology 2001;44:74-77
36. Lammers CH, Garcia-Borreguero D, Schmider J, et al. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls, 2. Biol Psychiatry 1995;38: 803-807
37. Ghaemi SN, Katzow JJ. The use of quetiapine for treatment-resistant bipolar disorder: a case series. Ann Clin Psychiatry 1999;11: 137-140
38. Sajatovic M, Brescan DW, Perez DE, et al. Quetiapine alone and added to a mood stabilizer for serious mood disorders. J Clin Psychiatry 2001;62:728-732
39. Sachs GS, Grossman F, Ghaemi SN, et al. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002;159:1146-1154
40. Sachs G, Mullen JA, Devine NA, et al. Quetiapine versus placebo as adjunct to mood stabilizer for the treatment of acute bipolar mania. Presented at the 3rd European Stanley Foundation Conference on Bipolar Disorder; September 12-14, 2002; Freiburg, Germany
41. Keck PJ, Ice K, Mandel F. A 3-week, double-blind, randomized trial of ziprasidone in the acute treatment of mania. Presented at the 22nd annual meeting of the Collegium Internationale Neuro-Psychopharmacologicum; July 9-13, 2000; Brussels, Belgium
42. Jody D, Marcus R, Keck P. Aripiprazole vs placebo in acute mania. Int J Neuropsychopharmacol 2002;5(suppl 1):S57
43. Glick ID, Murray SR, Vasudevan P, et al. Treatment with atypical antipsychotics: new indications and new populations. J Psychiatr Res 2001;35:187-191